Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Healthcare & Medical Investment's PEG Ratio or its related term are showing as below:
TSE:3455'
s PEG Ratio Range Over the Past 10 Years
Min: 11.18 Med: 14.51 Max: 23.59
Current: 13.05
During the past 11 years, Healthcare & Medical Investment's highest PEG Ratio was 23.59. The lowest was 11.18. And the median was 14.51.
TSE:3455's PEG Ratio is ranked worse than 81.88% of 276
companies
in the REITs industry
Industry Median: 3.48
vs TSE:3455: 13.05
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Healthcare & Medical Investment (TSE:3455) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Healthcare & Medical Investment PEG Ratio Related Terms
Healthcare & Medical Investment PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the REIT - Healthcare Facilities subindustry, Healthcare & Medical Investment's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthcare & Medical Investment PEG Ratio vs REITs Industry
For the REITs industry and Real Estate sector, Healthcare & Medical Investment's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Healthcare & Medical Investment's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Healthcare & Medical Investment (TSE:3455) has a PEG Ratio of 13.05 as of Aug. 01, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Healthcare & Medical Investment and its competitors. This is 10% below median its historical median of 14.51. Over the past decade, Healthcare & Medical Investment's PEG Ratio has ranged from 11.18 to 23.59. According to the industry distribution chart, Healthcare & Medical Investment ranks #226 out of 276 companies in the REITs industry, placing it in the top 81.9%.
Is Healthcare & Medical Investment's PEG Ratio too high?
Healthcare & Medical Investment's current PEG Ratio of 13.05 is 10% below median its 10-year median of 14.51. Over the past 10 years, this metric has ranged from a low of 11.18 to a high of 23.59. The REITs industry median PEG Ratio is 3.48. Healthcare & Medical Investment's value of 13.05 is 275% above this industry median. Based on the distribution chart, Healthcare & Medical Investment ranks #226 out of 276 companies in the REITs industry, which is in the bottom quartile relative to peers. Overall, Healthcare & Medical Investment has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthcare & Medical Investment's PEG Ratio compare to WELL and VTR?
According to the REITs industry distribution chart, Healthcare & Medical Investment ranks #226 out of 276 companies for PEG Ratio. This places Healthcare & Medical Investment in the lower half of its industry. The industry median PEG Ratio is 3.48. Healthcare & Medical Investment's value of 13.05 is 275% above this benchmark. Historically, Healthcare & Medical Investment's own PEG Ratio has ranged from 11.18 to 23.59 over the past decade. While the company's 10-year median is 14.51 vs. the industry median of 3.48, Healthcare & Medical Investment has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a REITs company?
The median PEG Ratio among REITs companies is 3.48, based on 276 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthcare & Medical Investment's current PEG Ratio of 13.05 is 275% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Healthcare & Medical Investment and its competitors. For the REITs industry, the median PEG Ratio is 3.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthcare & Medical Investment's current PEG Ratio is 13.05, which is 10% below median its own 10-year median of 14.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare & Medical Investment stock overvalued right now?
Based on GuruFocus' analysis, Healthcare & Medical Investment (TSE:3455) is currently considered Modestly Undervalued. The stock's GF Value™ is 円129,254.71, compared to a current price of 円105,400.00 — trading 18.5% below its estimated fair value. The current PEG Ratio is 13.05, which is 10% below median its 10-year median of 14.51 and 275% above the REITs industry median of 3.48. Healthcare & Medical Investment's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Healthcare & Medical Investment (TSE:3455), the current PEG Ratio is 13.05 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthcare & Medical Investment (TSE:3455) Overvalued in 2026?
Based on GuruFocus' analysis, Healthcare & Medical Investment stock appears to be undervalued.
The current stock price of 円105,400.00 is trading 18.5% below its estimated GF Value™ of 円129,254.71.
GuruFocus considers Healthcare & Medical Investment to be Modestly Undervalued.
Key valuation signals for TSE:3455:
PEG Ratio: 13.05 (10% below median its 10-year median of 14.51)
GF Value™: 円129,254.71 vs. price of 円105,400.00 (18.5% below fair value)
Industry Position: 275% above the REITs median (#226 of 276)
No single metric tells the full story. See the TSE:3455 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthcare & Medical Investment Corp is an investment company, which invests in nursing homes facilities and medical related real properties. The company aims to achieve stable earnings from mid- to long-term perspectives through investment in real estate and other related assets. The firm primarily invests in facilities and buildings for the elderly, as well as medical related facilities.
59GF Score
Get the complete analysis for TSE:3455
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3455 has been successfully added to your 
